For the Inventor, By the Inventor

Enter assignee name

Tarrytown, NY, United States of America

Usv Pharmaceutical Corporation

USPTO Granted Patents = 128

CIPO Patents = 5

Trademarks = 1

Forward Citations = 1,186

Loading Chart...

Loading Chart...

66 inventors (with patents filed for the assignee):

Bernard Loev (38 out of 44 patents)

Howard Jones (36 out of 72 patents)

John T Suh (34 out of 49 patents)

4. Wan-Kit Chan (15 out of 15 patents)

5. John H Musser (14 out of 113 patents)

6. Jerry W Skiles (14 out of 23 patents)

7. Fu-chih Huang (13 out of 18 patents)

8. Richard E Brown (12 out of 45 patents)

9. Raymond D Youssefyeh (12 out of 27 patents)

10. James R Shroff (11 out of 11 patents)

11. Bruce E Williams (10 out of 12 patents)

12. Edward S Neiss (8 out of 11 patents)

13. John J Piwinski (7 out of 72 patents)

14. Paul R Menard (6 out of 12 patents)

15. Alfred Schwab (6 out of 7 patents)

Core Competencies:

Cyclic Amides

Antihypertensive Compounds

Anti-Allergy Agents

Aryl Ethers

Quinoline Derivatives

Polyene Compounds

Angiotensin Inhibitors

Pharmaceutical Formulations

Dihydropyridines

Amino Acid Derivatives

Anti-Inflammatory

Ischemic Heart Treatments

128 patents: Sort by Forward Citations

1. 5200416 - Cyclic amides (1993-04-06),

2. 4794188 - Certain unsymmetrical quinolinyl ethers having anti-inflammatory and (1988-12-27),

3. 4778931 - Certain [3-(1-hydroxy hexyl-tetrahydro)naphthalenes], the corresponding (1988-10-18),

4. 4762945 - Process for the preparation of aspirin peroxide (1988-08-09),

5. 4758586 - Indolyl compounds and hyposensitivity use thereof (1988-07-19),

6. 4740373 - Stabilization of multivitamin/trace elements formulations (1988-04-26),

7. 4728668 - Aryl and heteroaryl ethers as agents for the treatment of hypersensitive (1988-03-01),

8. 4725619 - Aryl and heteroaryl ethers as agents for the treatment of hypersensitive (1988-02-16),

9. 4722939 - Derivatives of alpha-alkyl polyolefinic carboxylic acid useful in the (1988-02-02),

10. 4701461 - Substituted cyclic amines (1987-10-20),

11. 4698346 - Thiazolo[5,4-h]quinoline compounds useful as anti-allergy agents (1987-10-06),

12. 4696939 - Benzothiadiazole compounds for treating hypertension (1987-09-29),

13. 4694023 - Alpha-alkyl polyolefinic carboxylic acids and derivatives thereof useful (1987-09-15),

14. 4686295 - N-carboxy anhydride intermediates (1987-08-11),

15. 4681973 - Direct n-acylation of amino acids (1987-07-21),

Company Overview

Usv Pharmaceutical Corporation, headquartered in Tarrytown, NY, specializes in the development and manufacturing of pharmaceutical compounds. The company focuses on a diverse range of therapeutic areas, including antihypertensive and anti-allergy agents, leveraging advanced technologies such as cyclic amides and quinoline derivatives. Usv is committed to innovation in pharmaceutical formulations, aiming to enhance patient outcomes through effective and reliable medication solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

128 Patents

#7 in Tarrytown, NY

#192 in New York

#3,032 in US

#6,271 in the World

Tarrytown, NY, United States of America

Usv Pharmaceutical Corporation

Forward Citations = 1,186

66 inventors:

Bernard Loev (38 out of 44 patents)

Howard Jones (36 out of 72 patents)

John T Suh (34 out of 49 patents)

4. Wan-Kit Chan (15 out of 15 patents)

5. John H Musser (14 out of 113 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Usv Pharmaceutical Corporation. Retrieved from https://idiyas.com/company/usv-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…